Ibrutinib and rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone in patients with previously untreated non-germinal centre B-cell-like diffuse large B-cell lymphoma: A Chinese subgroup analysis of the phase III PHOENIX trial.

China DLBCL ibrutinib previously untreated

Journal

EJHaem
ISSN: 2688-6146
Titre abrégé: EJHaem
Pays: United States
ID NLM: 101761942

Informations de publication

Date de publication:
Nov 2022
Historique:
received: 09 06 2022
accepted: 10 06 2022
entrez: 5 12 2022
pubmed: 6 12 2022
medline: 6 12 2022
Statut: epublish

Résumé

In this post hoc subgroup analysis of 200 patients enrolled in China from the phase III PHOENIX trial (

Identifiants

pubmed: 36467814
doi: 10.1002/jha2.517
pii: JHA2517
pmc: PMC9713042
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1154-1164

Informations de copyright

© 2022 The Authors. eJHaem published by British Society for Haematology and John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

S W, S M S, S S, Y Z, and J V: Janssen employment and stock ownership from Johnson and Johnson; B H, Z W, X W and Y F: Janssen employment; J Z, X H, Y S, S B, Q Z, Y S, H H, H Z and WW have no conflict of interest to disclose.

Références

Am J Clin Pathol. 2010 Feb;133(2):305-13
pubmed: 20093241
Diagn Pathol. 2011 Aug 22;6:77
pubmed: 21854649
J Clin Oncol. 2012 Oct 1;30(28):3460-7
pubmed: 22665537
Ann Hematol. 2012 Jun;91(6):837-45
pubmed: 22160255
PLoS One. 2014 Aug 04;9(8):e104068
pubmed: 25090026
J Hematol Oncol. 2019 Nov 19;12(1):115
pubmed: 31744509
ScientificWorldJournal. 2012;2012:897178
pubmed: 23213304
Chin Med J (Engl). 2018 Aug 05;131(15):1767-1775
pubmed: 30058572
Zhonghua Xue Ye Xue Za Zhi. 2012 Apr;33(4):257-60
pubmed: 22781712
Ann Oncol. 2015 Sep;26 Suppl 5:v116-25
pubmed: 26314773
Chin J Cancer Res. 2019 Aug;31(4):557-577
pubmed: 31564800
Lancet. 2017 Sep 16;390(10100):1151-1210
pubmed: 28919116
FASEB J. 2010 Oct;24(10):3643-52
pubmed: 20530750
Blood. 2012 Nov 8;120(19):3986-96
pubmed: 22955915
Ai Zheng. 2005 Dec;24(12):1421-6
pubmed: 16351785
Cell Death Dis. 2018 Jun 28;9(7):732
pubmed: 29955050
J Clin Pathol. 2020 Mar;73(3):126-138
pubmed: 31615842
Chin J Cancer Res. 2019 Feb;31(1):152-161
pubmed: 30996573
Blood. 2008 Oct 15;112(8):3088-98
pubmed: 18559976
Circ Heart Fail. 2015 Jan;8(1):175-87
pubmed: 25339503
Mol Cell. 2017 Mar 16;65(6):999-1013.e7
pubmed: 28306514
Medicine (Baltimore). 2018 Aug;97(35):e12120
pubmed: 30170444
J Clin Oncol. 2019 May 20;37(15):1285-1295
pubmed: 30901302

Auteurs

Jun Zhu (J)

Beijing University Cancer Hospital and Institute Beijing China.

Xiaonan Hong (X)

Fudan University Cancer Hospital Shanghai China.

Yu Qin Song (YQ)

Beijing University Cancer Hospital and Institute Beijing China.

Brendan Hodkinson (B)

Oncology Translational Research Janssen Research and Development Spring House Pennsylvania USA.

Sriram Balasubramanian (S)

Oncology Translational Research Janssen Research and Development San Diego California USA.

Songbai Wang (S)

Oncology Translational Research Janssen Research and Development Raritan New Jersey USA.

Qingyuan Zhang (Q)

Affiliated Cancer Hospital of Harbin Medical University Harbin China.

Yuankai Shi (Y)

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing Key Laboratory of Clinical Study on Anticancer Molecular Targeted Drugs Beijing China.

Huiqiang Huang (H)

Sun Yat-sen University Cancer Center Guangzhou China.

Huilai Zhang (H)

Tianjin Cancer Hospital Heping China.

Yan Zhu (Y)

Janssen Research and Development Raritan New Jersey USA.

Stephen Martin Shreeve (SM)

Clinical Oncology Janssen Research and Development San Diego California USA.

Steven Sun (S)

Clinical Biostats Janssen Research and Development Raritan New Jersey USA.

Ze Wang (Z)

Xian Janssen Pharmaceuticals Medical Affairs Beijing China.

Xiaocan Wang (X)

Xian Janssen Pharmaceuticals Medical Affairs Beijing China.

Yue Fan (Y)

Oncology Translational Research Janssen Research and Development Shanghai China.

Wyndham Wilson (W)

National Cancer Institute National Institutes of Health Bethesda Maryland USA.

Jessica Vermeulen (J)

Clinical Oncology Janssen Research and Development Leiden The Netherlands.

Classifications MeSH